Maternal medicine in the COVID era

Sophie Relph; Shakila Thangaratinam

doi:10.1016/j.bpobgyn.2021.03.003

Maternal medicine in the COVID era

Sophie Relph, Shakila Thangaratinam

Metabolism and Systems Research

Research output: Contribution to journal › Review article › peer-review

Abstract

The coronavirus disease-19 (COVID-19) pandemic has directly and indirectly impacted pregnant women with co-morbidities or antenatal medical complications, through vulnerability to the severe effects of COVID-19 and service reconfiguration. Women with diabetes or hypertension in pregnancy are at higher risk of admission to intensive care, need for invasive ventilation and death from COVID-19. Suggested service modifications specific to maternal medicine services include home measurement of blood glucose or blood pressure, the use of risk calculators, adaptations to screening criteria for gestational diabetes and monitoring of obstetric cholestasis. Neither the added risk of COVID-19 on pregnant women with medical comorbidities nor the impact of maternal medicine service modifications has yet been established.

Original language	English
Pages (from-to)	113-124
Journal	Best Practice & Research: Clinical Obstetrics & Gynaecology
Volume	73
Early online date	18 Mar 2021
DOIs	https://doi.org/10.1016/j.bpobgyn.2021.03.003
Publication status	Published - Jun 2021

Keywords

COVID-19
Co-morbidities
Maternal medicine
Pregnancy
Prenatal care
SARS-CoV-2
Pandemics
Humans
Pregnancy Complications, Infectious/epidemiology
Pregnant Women
Female

ASJC Scopus subject areas

Obstetrics and Gynaecology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.bpobgyn.2021.03.003Licence: None: All rights reserved

Cite this

@article{7eb70c17ae364eeb913d989b2645ccfb,

title = "Maternal medicine in the COVID era",

abstract = "The coronavirus disease-19 (COVID-19) pandemic has directly and indirectly impacted pregnant women with co-morbidities or antenatal medical complications, through vulnerability to the severe effects of COVID-19 and service reconfiguration. Women with diabetes or hypertension in pregnancy are at higher risk of admission to intensive care, need for invasive ventilation and death from COVID-19. Suggested service modifications specific to maternal medicine services include home measurement of blood glucose or blood pressure, the use of risk calculators, adaptations to screening criteria for gestational diabetes and monitoring of obstetric cholestasis. Neither the added risk of COVID-19 on pregnant women with medical comorbidities nor the impact of maternal medicine service modifications has yet been established.",

keywords = "COVID-19, Co-morbidities, Maternal medicine, Pregnancy, Prenatal care, SARS-CoV-2, Pandemics, Humans, Pregnancy Complications, Infectious/epidemiology, Pregnant Women, Female",

author = "Sophie Relph and Shakila Thangaratinam",

year = "2021",

month = jun,

doi = "10.1016/j.bpobgyn.2021.03.003",

language = "English",

volume = "73",

pages = "113--124",

journal = "Best Practice & Research: Clinical Obstetrics & Gynaecology",

issn = "1521-6934",

publisher = "Elsevier",

}

TY - JOUR

T1 - Maternal medicine in the COVID era

AU - Relph, Sophie

AU - Thangaratinam, Shakila

PY - 2021/6

Y1 - 2021/6

N2 - The coronavirus disease-19 (COVID-19) pandemic has directly and indirectly impacted pregnant women with co-morbidities or antenatal medical complications, through vulnerability to the severe effects of COVID-19 and service reconfiguration. Women with diabetes or hypertension in pregnancy are at higher risk of admission to intensive care, need for invasive ventilation and death from COVID-19. Suggested service modifications specific to maternal medicine services include home measurement of blood glucose or blood pressure, the use of risk calculators, adaptations to screening criteria for gestational diabetes and monitoring of obstetric cholestasis. Neither the added risk of COVID-19 on pregnant women with medical comorbidities nor the impact of maternal medicine service modifications has yet been established.

AB - The coronavirus disease-19 (COVID-19) pandemic has directly and indirectly impacted pregnant women with co-morbidities or antenatal medical complications, through vulnerability to the severe effects of COVID-19 and service reconfiguration. Women with diabetes or hypertension in pregnancy are at higher risk of admission to intensive care, need for invasive ventilation and death from COVID-19. Suggested service modifications specific to maternal medicine services include home measurement of blood glucose or blood pressure, the use of risk calculators, adaptations to screening criteria for gestational diabetes and monitoring of obstetric cholestasis. Neither the added risk of COVID-19 on pregnant women with medical comorbidities nor the impact of maternal medicine service modifications has yet been established.

KW - COVID-19

KW - Co-morbidities

KW - Maternal medicine

KW - Pregnancy

KW - Prenatal care

KW - SARS-CoV-2

KW - Pandemics

KW - Humans

KW - Pregnancy Complications, Infectious/epidemiology

KW - Pregnant Women

KW - Female

UR - http://www.scopus.com/inward/record.url?scp=85103938421&partnerID=8YFLogxK

U2 - 10.1016/j.bpobgyn.2021.03.003

DO - 10.1016/j.bpobgyn.2021.03.003

M3 - Review article

C2 - 33839044

SN - 1521-6934

VL - 73

SP - 113

EP - 124

JO - Best Practice & Research: Clinical Obstetrics & Gynaecology

JF - Best Practice & Research: Clinical Obstetrics & Gynaecology

ER -

Maternal medicine in the COVID era

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this